Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

DMAC Insider Trading

Insider Ownership Percentage: 6.50%
Insider Buying (Last 12 Months): $6,243,249.61
Insider Selling (Last 12 Months): $0.00

DiaMedica Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at DiaMedica Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DiaMedica Therapeutics Share Price & Price History

Current Price: $3.06
Price Change: Price Increase of +0.06 (2.00%)
As of 03/1/2024 01:07 PM ET

This chart shows the closing price history over time for DMAC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

DiaMedica Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/23/2023David J WambekeInsiderBuy38,364$3.91$150,003.24507,114View SEC Filing Icon  
6/23/2023Dietrich John PaulsCEOBuy12,787$3.91$49,997.1768,591View SEC Filing Icon  
6/23/2023Koch Thomas VonMajor ShareholderBuy1,470,588$3.40$4,999,999.204,326,435View SEC Filing Icon  
6/23/2023Randall Michael GiuffreDirectorBuy65,000$3.91$254,150.00360,355View SEC Filing Icon  
6/23/2023Scott KellenCFOBuy10,000$3.91$39,100.0032,290View SEC Filing Icon  
4/10/2023David J WambekeInsiderBuy468,750$1.60$750,000.00468,750View SEC Filing Icon  
12/8/2022Randall Michael GiuffreDirectorBuy20,000$1.40$28,000.00223,146View SEC Filing Icon  
12/6/2022Randall Michael GiuffreDirectorBuy2,300$1.35$3,105.00180,572View SEC Filing Icon  
12/1/2022Randall Michael GiuffreDirectorBuy46,133$1.20$55,359.60177,453View SEC Filing Icon  
11/29/2022Randall Michael GiuffreDirectorBuy18,125$1.19$21,568.75128,350View SEC Filing Icon  
11/16/2022Dietrich John PaulsCEOBuy20,000$1.21$24,200.0055,804View SEC Filing Icon  
7/8/2022Koch Thomas VonMajor ShareholderBuy207,974$1.33$276,605.422,855,827View SEC Filing Icon  
9/15/2021Harry W. Alcorn, Jr.SVPBuy15,000$3.80$57,000.0043,582View SEC Filing Icon  
8/16/2021Dietrich John PaulsCEOBuy5,000$3.14$15,700.00View SEC Filing Icon  
8/16/2021Harry W. Alcorn, Jr.VPBuy20,322$3.09$62,794.98View SEC Filing Icon  
8/16/2021Richard D. PilnikDirectorBuy15,000$3.27$49,050.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for DiaMedica Therapeutics (NASDAQ:DMAC)

6.42% of DiaMedica Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DMAC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

DiaMedica Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Vanguard Group Inc.802,171$2.28M0.0%+1.7%2.114%Search for SEC Filing on Google Icon
2/15/2024Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp133,633$0.38M0.0%+49.0%0.352%Search for SEC Filing on Google Icon
2/7/2024Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.788,789$2.04M0.0%+0.7%2.078%Search for SEC Filing on Google Icon
11/15/2023Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp89,700$0.23M0.0%+9.2%0.236%Search for SEC Filing on Google Icon
11/13/2023EAM Investors LLC212,512$0.55M0.1%-21.4%0.560%Search for SEC Filing on Google Icon
11/9/2023Bleichroeder LP222,317$0.57M0.1%-24.4%0.586%Search for SEC Filing on Google Icon
11/1/2023Jacob Asset Management of New York LLC168,730$0.44M0.6%-15.1%0.445%Search for SEC Filing on Google Icon
8/30/2023Cooperman Leon G875,993$3.78M0.2%+0.9%2.308%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp82,160$0.36M0.0%-9.5%0.305%Search for SEC Filing on Google Icon
8/10/2023Jacob Asset Management of New York LLC198,730$0.86M1.0%-15.0%0.738%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.13,251$57K0.0%N/A0.049%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC9,800$42K0.0%+344.6%0.036%Search for SEC Filing on Google Icon
8/2/2023Catalyst Financial Partners LLC36,267$0.16M0.1%+44.4%0.135%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC64,508$99K0.0%+91.9%0.244%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP16,959$26K0.0%-60.2%0.064%Search for SEC Filing on Google Icon
4/11/2023Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC20,840$33K0.0%+108.3%0.079%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC33,619$53K0.0%N/A0.127%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC34,912$43K0.0%+93.8%0.132%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP42,634$53K0.0%-26.5%0.161%Search for SEC Filing on Google Icon
5/16/2022State Street Corp66,629$0.17M0.0%+11.6%0.252%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP58,015$0.15M0.0%+387.5%0.219%Search for SEC Filing on Google Icon
5/12/2022Jacob Asset Management of New York LLC265,000$0.66M0.4%-3.6%1.002%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp36,412$91K0.0%-27.0%0.138%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP10,031$40K0.0%-93.6%0.053%Search for SEC Filing on Google Icon
11/15/2021Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC165,775$0.67M0.3%-60.5%0.882%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC18,300$73K0.0%N/A0.097%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.55,970$0.23M0.0%-8.6%0.298%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP155,662$0.69M0.0%+104.9%0.829%Search for SEC Filing on Google Icon
8/16/2021State Street Corp30,217$0.13M0.0%N/A0.161%Search for SEC Filing on Google Icon
8/16/2021Corriente Advisors LLC203,641$0.91M0.5%-76.6%1.084%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP155,662$0.69M0.0%+104.9%0.829%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC94,100$0.42M0.0%-38.5%0.501%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC133,569$0.59M0.0%+4.0%0.711%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP17,019$76K0.0%N/A0.091%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.8,299$37K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/12/2021Bank of Montreal Can142,846$0.69M0.0%+36.7%0.760%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC20,601$0.19M0.0%N/A0.110%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC35,536$0.33M0.0%N/A0.189%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC70,281$0.64M0.0%+72.0%0.374%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940%Search for SEC Filing on Google Icon
5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC20,601$0.19M0.0%N/A0.110%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC3,412$31K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp40,576$0.37M0.0%-5.4%0.216%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can104,524$0.98M0.0%+27.7%0.556%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp85,026$0.78M0.0%-29.7%0.453%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684%Search for SEC Filing on Google Icon
5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981%Search for SEC Filing on Google Icon
5/11/2021EAM Investors LLC108,232$0.99M0.1%-1.6%0.576%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.60,165$0.55M0.0%+7.9%0.320%Search for SEC Filing on Google Icon
4/27/2021Dorsey Wright & Associates3,937$36K0.4%N/A0.021%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC15,712$0.16M0.0%N/A0.084%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC12,537$0.13M0.0%N/A0.067%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP13,160$0.13M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/12/2021Stonepine Capital Management LLC950,000$9.63M7.4%-17.1%5.070%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp120,989$1.23M0.0%+3.6%0.646%Search for SEC Filing on Google Icon
2/11/2021Valeo Financial Advisors LLC5,000$51K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp42,905$0.44M0.0%+218.5%0.229%Search for SEC Filing on Google Icon
2/6/2021Granite Point Capital Management L.P.546,855$5.55M0.3%-15.5%2.918%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.55,781$0.57M0.0%+27.4%0.298%Search for SEC Filing on Google Icon
11/17/2020Nantahala Capital Management LLC756,193$3.21M0.1%+0.8%4.035%Search for SEC Filing on Google Icon
11/16/2020Point72 Asset Management L.P.800,000$3.39M0.0%N/A4.269%Search for SEC Filing on Google Icon
11/16/2020Worth Venture Partners LLC42,887$0.18M0.1%N/A0.229%Search for SEC Filing on Google Icon
11/16/2020Manatuck Hill Partners LLC571,500$2.42M1.1%+62.8%3.050%Search for SEC Filing on Google Icon
11/16/2020Boothbay Fund Management LLC46,562$0.20M0.0%N/A0.248%Search for SEC Filing on Google Icon
11/13/2020Stonepine Capital Management LLC1,146,470$4.86M5.1%+71.5%6.118%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley9,100$38K0.0%+56.9%0.049%Search for SEC Filing on Google Icon
11/6/2020Granite Point Capital Management L.P.646,855$2.74M0.1%+35.5%3.452%Search for SEC Filing on Google Icon
11/3/2020Corriente Advisors LLC730,000$3.10M1.6%+262.7%3.895%Search for SEC Filing on Google Icon
8/14/2020Corriente Advisors LLC201,248$1.40M0.9%N/A1.423%Search for SEC Filing on Google Icon
8/12/2020Bank of New York Mellon Corp13,472$93K0.0%N/A0.095%Search for SEC Filing on Google Icon
5/14/2020Stonepine Capital Management LLC825,297$2.31M2.4%N/A5.837%Search for SEC Filing on Google Icon
5/1/2020BlackRock Inc.38,373$0.11M0.0%+19.7%0.271%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC17,557$85K0.0%+14.0%0.147%Search for SEC Filing on Google Icon
2/13/2020Blair William & Co. IL10,000$49K0.0%N/A0.084%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
DiaMedica Therapeutics logo
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company develops treatments for neurological disorders and cardio-renal disease. Its lead candidate is DM199, a pharmaceutically active recombinant form of the kallikrein-1 protein for the treatment of acute ischemic stroke and other vascular diseases. It is also developing DM300 that is in preclinical stage of development for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Read More on DiaMedica Therapeutics

Today's Range

Now: $3.06
Low: $2.95
High: $3.11

50 Day Range

MA: $2.90
Low: $2.58
High: $3.23

52 Week Range

Now: $3.06
Low: $1.46
High: $4.75

Volume

11,559 shs

Average Volume

40,777 shs

Market Capitalization

$116.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of DiaMedica Therapeutics?

DiaMedica Therapeutics' top insider shareholders include:
  1. Koch Thomas Von (Major Shareholder)
  2. David J Wambeke (Insider)
  3. Randall Michael Giuffre (Director)
  4. Dietrich John Pauls (CEO)
  5. Scott Kellen (CFO)
Learn More about top insider investors at DiaMedica Therapeutics.

Who are the major institutional investors of DiaMedica Therapeutics?

DiaMedica Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 2.11%
  2. Paragon Associates & Paragon Associates II Joint Venture — 1.32%
  3. Northern Trust Corp — 0.35%
  4. Avantax Advisory Services Inc. — 0.03%
  5. Simplex Trading LLC — 0.00%
  6. Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of DiaMedica Therapeutics stock.

Which institutional investors are selling DiaMedica Therapeutics stock?

During the last quarter, DMAC stock was sold by these institutional investors:
  1. Simplex Trading LLC

Which institutional investors are buying DiaMedica Therapeutics stock?

In the previous quarter, DMAC stock was purchased by institutional investors including:
  1. Northern Trust Corp
  2. Paragon Associates & Paragon Associates II Joint Venture
  3. Vanguard Group Inc.
  4. Avantax Advisory Services Inc.
  5. Citadel Advisors LLC
Within the previous year, these company insiders have bought DiaMedica Therapeutics stock:
  1. Koch Thomas Von (Major Shareholder)
  2. David J Wambeke (Insider)
  3. Randall Michael Giuffre (Director)
  4. Dietrich John Pauls (CEO)
  5. Scott Kellen (CFO)
Learn More investors buying DiaMedica Therapeutics stock.